How to transport medicines
A dual heat-retaining system with external and battery-powered devices ensures temperature control compliance with GDP guidelines during pharmaceutical transportation, addressing power disruptions and reducing power consumption.
Patent Information
- Application Number
- JP2020198738
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-11-30
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2040-11-30
AI Technical Summary
Existing temperature control methods for pharmaceutical transportation during long-term distribution may fail to meet Good Distribution Practice (GDP) guidelines due to power supply disruptions during transportation mode changes.
A dual heat-retaining system comprising a first device driven by an external power source and a second device powered by a secondary battery, allowing temperature control within specific ranges using a first, second, and third temperature range, respectively, to ensure compliance with GDP guidelines even during power interruptions.
The system effectively maintains pharmaceutical temperatures within required ranges, ensuring compliance with GDP guidelines and reducing power consumption by optimizing temperature control strategies.
Smart Images

Figure 0007581027000001 
Figure 0007581027000002 
Figure 0007581027000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for delivering a pharmaceutical agent. [Background technology]
[0002] Conventionally, pharmaceuticals are transported by land transportation means, sea transportation means, air transportation means, etc., in a state where they are contained in a heat-retaining device capable of controlling the internal temperature, such as a reefer container. As a technology for transporting cargo with the internal temperature controlled, for example, a transportation method such as that disclosed in Patent Document 1 is known. Patent Document 1 discloses a transportation method for transporting cargo using a thermally insulated container. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2019-43651 A Summary of the Invention [Problem to be solved by the invention]
[0004] Regarding the distribution of pharmaceuticals, the Ministry of Health, Labour and Welfare issued the Good Distribution Practice (GDP) Guidelines for Pharmaceuticals in December 2018. During long-distance transportation, the heat-retention devices that contain pharmaceuticals may not be able to secure power due to changes in the means of transportation, etc. In such cases, it becomes difficult to properly manage the temperature of the pharmaceuticals, and it may not be possible to transport pharmaceuticals in accordance with the GDP guidelines.
[0005] Therefore, an object of the present invention is to provide a transportation method that appropriately controls the temperature of pharmaceuticals during long-term transportation. [Means for solving the problem]
[0006] The present invention provides a method for transporting pharmaceuticals using a first insulation device powered by an external power source and controlling the internal temperature within a first temperature range, and a second insulation device powered by a secondary battery and controlling the internal temperature within a second temperature range, the method comprising the steps of housing the second insulation device within the first insulation device and transporting the first insulation device with the pharmaceutical contained within the second insulation device, wherein the first temperature range is set between a value that is a predetermined range higher than the lower limit value of the second temperature range and the upper limit value of the second temperature range.
[0007] Furthermore, when multiple second insulation devices are housed within the first insulation device, at least one of the second insulation devices is capable of controlling the internal temperature within a third temperature range, and the third temperature range is a temperature range lower than the second temperature range. Effect of the Invention
[0008] According to the present invention, the temperature of a pharmaceutical product can be appropriately controlled during long-term transportation. [Brief description of the drawings]
[0009] [Figure 1] FIG. 2 is a diagram illustrating a state in which a first heat retention device and a second heat retention device according to the present embodiment are transported by land. [Diagram 2] FIG. 2 is a diagram showing a schematic diagram of a state in which a first heat retention device and a second heat retention device according to the present embodiment are transported by sea. [Diagram 3] FIG. 2 is a block diagram showing a functional configuration of a first heat retention device according to the present embodiment. [Figure 4] FIG. 4 is a block diagram showing a functional configuration of a second heat retention device according to the present embodiment. [Diagram 5] 2 is a flowchart showing the process flow of a pharmaceutical transportation method according to the present embodiment. [Figure 6] FIG. 4 is a diagram showing a state of management of the internal temperatures of a first heat retaining device and a second heat retaining device according to the present embodiment. [Figure 7]7 is a table showing the results of a demonstration test using the first heat retention device and the second heat retention device shown in FIG. 6. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings. The pharmaceutical transportation method according to this embodiment aims to appropriately manage the temperature of the pharmaceutical during long-term transportation by using a first heat retention device 1 and a second heat retention device 2.
[0011] FIG. 1 is a diagram that shows a schematic diagram of a state in which a first heat retention device 1 and a second heat retention device 2 according to this embodiment are transported by land.
[0012] As shown in Figure 1, the pharmaceutical transportation method of this embodiment includes a step of containing a second insulation device 2 inside a first insulation device 1, and transporting the first insulation device 1 by land transportation means 3 with the pharmaceutical contained in the second insulation device 2.
[0013] The first heat retention device 1 is driven by an external power source and controls the internal temperature within a first temperature range. The first heat retention device 1 is, for example, a reefer container.
[0014] The second heat retaining device 2 is driven by a secondary cell such as a battery, and controls the internal temperature within a second temperature range. The second heat retaining device 2 is, for example, a Cold Roll Box (CRB). The above-mentioned first temperature range and second temperature range will be described later.
[0015] The land transportation means 3 is, for example, a transportation vehicle such as a trailer, and transports the first insulation device 1 by land with the medicine contained in the second insulation device 2. In addition, the land transportation means 3 has a power supply unit and is capable of supplying power to the first insulation device 1.
[0016] FIG. 2 is a diagram that shows a schematic diagram of a state in which the first heat retention device 1 and the second heat retention device 2 according to this embodiment are transported by sea.
[0017] As shown in Figure 2, the method of transporting pharmaceuticals in this embodiment includes a step of containing a second insulation device 2 inside a first insulation device 1, and transporting the first insulation device 1 by marine transportation means 4 with the pharmaceuticals contained in the second insulation device 2.
[0018] The marine transport means 4 is, for example, a transport vessel such as a cargo ship, and transports the first insulation device 1 by sea with the medicine contained in the second insulation device 2. The marine transport means 4 also has a power supply unit and is capable of supplying power to the first insulation device 1.
[0019] FIG. 3 is a block diagram showing the functional configuration of the first heat retention device 1 according to this embodiment. As shown in FIG. 3, the first heat retention device 1 is, for example, a reefer container, and includes a storage unit 11, a heat retention mechanism 12, and a power supply unit 13.
[0020] The accommodation section 11 defines a space for accommodating the second heat retention device 2. The accommodation section 11 is composed of, for example, a door, an outer casing, an inner casing, and the like. The heat retention mechanism 12 is a mechanism for maintaining the temperature of the second heat retention device 2 housed in the housing section 11. The heat retention mechanism 12 is composed of, for example, a compressor, a condenser, an evaporator, a condensation fan, an evaporator fan, a control box, and the like.
[0021] The power supply unit 13 receives power from the land transportation means 3 and drives the heat retention mechanism 12 with the supplied power.
[0022] FIG. 4 is a block diagram showing the functional configuration of the second heat retaining device 2 according to this embodiment. As shown in FIG. 4, the second heat retention device 2 is, for example, a CRB, and includes a storage section 21, a heat retention mechanism 22, a secondary battery 23, and a temperature data communication section 24.
[0023] The storage section 21 defines a space for storing medicines. The storage section 21 is composed of, for example, a door, a casing, casters, and the like.
[0024] The heat retention mechanism 22 is a mechanism for keeping warm the medicine contained in the container 21. The heat retention mechanism 22 is composed of, for example, a refrigerant, an evaporation pipe, an internal fan motor, a condenser fan motor, a condenser, a compressor, and the like. The secondary battery 23 is formed of, for example, a rechargeable battery, and drives the heat retention mechanism 22 .
[0025] The temperature data communication unit 24 detects the temperature inside the storage unit 21 at regular intervals and records the detected temperature data. The temperature data communication unit 24 is also capable of wireless communication with an external device and transmits the recorded temperature data to the external device. For example, the temperature data communication unit 24 transmits the temperature data recorded during land transportation by the land transportation means 3 to the external device.
[0026] FIG. 5 is a flowchart showing the process flow of the pharmaceutical transportation method according to this embodiment. In step S1, the transportation method includes placing a second heat retention device 2 in a first heat retention device 1, and placing a medicine in the second heat retention device 2.
[0027] In step S2, the transportation method involves operating the first heat retention device 1 and the second heat retention device 2, and transporting the medicines contained in the first heat retention device 1 and the second heat retention device 2 by land transportation means 3.
[0028] In step S3, the transportation method involves stopping the operation of the first insulation device 1 and operating the second insulation device 2, and transferring the pharmaceuticals contained in the first insulation device 1 and the second insulation device 2 from land transportation means 3 to sea transportation means 4.
[0029] In step S4, the transportation method involves transporting the pharmaceuticals contained in the first insulation device 1 and the second insulation device 2 by sea transport means 4 while the first insulation device 1 and the second insulation device 2 are in operation.
[0030] In step S5, the transportation method involves stopping the operation of the first insulation device 1 and operating the second insulation device 2, and transferring the pharmaceuticals contained in the first insulation device 1 and the second insulation device 2 from the marine transportation means 4 to the land transportation means 3.
[0031] In step S6, the transportation method involves transporting the medicines contained in the first insulation device 1 and the second insulation device 2 by land transportation means 3 while the first insulation device 1 and the second insulation device 2 are operating.
[0032] In this way, the pharmaceutical transportation method of this embodiment transports pharmaceuticals using a first insulation device 1 and a second insulation device 2, so that pharmaceuticals can be transported in accordance with GDP guidelines even if the operation of the first insulation device 1 stops due to a switch in transportation means (steps S3 and S5 above).
[0033] FIG. 6 is a diagram showing a state of management of the internal temperatures of the first heat retaining device 1 and the second heat retaining devices 2a and 2b according to this embodiment. In the example shown in Fig. 6, the first heat retaining device 1 manages the temperature in a first temperature range, the second heat retaining device 2b manages the temperature in a second temperature range (20°C range), and the second heat retaining device 2a manages the temperature in a third temperature range (5°C range).
[0034] As described above, the method of transporting pharmaceuticals in this embodiment involves containing the second insulation device 2a, 2b in the first insulation device 1, and transporting the first insulation device 1 by land transportation means 3 with the pharmaceuticals contained in the second insulation device 2a, 2b.
[0035] During the switch from the land transportation means 3 to the marine transportation means 4, the power supply to the first heat retention device 1 is stopped.
[0036] On the other hand, the second heat retention device 2b is powered by the secondary battery 23 during the switch from the land transportation means 3 to the marine transportation means 4 and during transportation by the marine transportation means 4, and manages the internal temperature within a second temperature range. Similarly, the second heat retention device 2a is powered by a secondary battery 23 while switching from the land transportation means 3 to the marine transportation means 4 and while being transported by the marine transportation means 4, and controls the internal temperature within a third temperature range.
[0037] In this way, in the pharmaceutical transportation method according to this embodiment, even if the second heat keeping devices 2a, 2b do not have an external power source, the second heat keeping devices 2a, 2b operate using the secondary battery 23, and therefore, even if the power supply to the first heat keeping device 1 is stopped for a short time, the temperature inside the second heat keeping devices 2a, 2b can be appropriately controlled. Therefore, according to the pharmaceutical transportation method according to this embodiment, the temperature of the pharmaceutical can be appropriately controlled during long-term transportation, and the pharmaceutical can be transported in accordance with the GDP guidelines.
[0038] Furthermore, in the pharmaceutical transportation method of this embodiment, by containing the second insulation device 2 in the first insulation device 1 and containing the pharmaceutical in the second insulation device 2, it becomes possible to control the temperature (space temperature) inside the second insulation device 2 in which the pharmaceutical is contained, and the temperature of the pharmaceutical can be appropriately controlled during long-term transportation without being affected by the outside air temperature.
[0039] Here, the first temperature range is set between a value (17° C.) that is a predetermined range higher than the lower limit of the second temperature range and the upper limit of the second temperature range.
[0040] Specifically, when the second temperature range is set to 15°C to 25°C, the first temperature range is set between a value (17°C) that is a predetermined range (2°C) higher than the lower limit (15°C) of the second temperature range (15°C to 25°C) and the upper limit (25°C) of the second temperature range (15°C to 25°C). In other words, when the second temperature range is set to 15°C to 25°C, the first temperature range is set to 17°C to 25°C.
[0041] In this manner, in the pharmaceutical transportation method of this embodiment, by setting the first temperature range between a temperature higher than the lower limit of the second temperature range and the upper limit of the second temperature range, the first temperature range and the second temperature range are relatively close to each other, thereby making it possible to reduce the power consumption of the second heat retention device 2b.
[0042] In addition, when multiple second insulation devices 2a, 2b are housed within the first insulation device 1, at least one of the second insulation devices 2a is powered by a secondary battery 23 while being transported by sea transport means 4, and the internal temperature can be controlled within a third temperature range.
[0043] The third temperature range is a temperature range lower than the second temperature range. Specifically, when the second temperature range is set to 15°C to 25°C, the third temperature range is set to, for example, 2°C to 8°C.
[0044] As described above, the second heat retention device 2a, 2b is, for example, a Cold Roll Box (CRB), and generally, a CRB can consume less power when cooling the internal temperature than when heating the internal temperature.
[0045] Therefore, the pharmaceutical transportation method of this embodiment can reduce the power consumption of the second heat retention device 2a by setting the third temperature range (2°C to 8°C: 5°C range) to a lower temperature range than the second temperature range (15°C to 25°C).
[0046] In addition, the pharmaceutical transport method of this embodiment may transport the pharmaceutical using a different temperature range instead of the specific examples of the first temperature range (17°C to 25°C), the second temperature range (15°C to 25°C), and the third temperature range (2°C to 8°C) described above.
[0047] For example, in the pharmaceutical transportation method according to the present embodiment, the first temperature range is set to 2°C to 8°C (5°C range), and the second temperature range is set to 2°C to 8°C (5°C range). )、The medicine may be transported with the third temperature range being −15° C. to −25° C. (−20° C. range). In this way, the medicine transport method according to the present embodiment can appropriately manage medicines that must be stored at a low temperature range during long-term transportation.
[0048] Fig. 7 is a table showing the results of a demonstration test using the first heat retention device 1 and the second heat retention devices 2a and 2b shown in Fig. 6. In the demonstration test, the temperature management state of medicines was tested using the above-mentioned first heat retention device 1 and the second heat retention devices 2a and 2b.
[0049] Specifically, as shown in FIG. 6, the second heat-retaining devices 2a and 2b were housed in the first heat-retaining device 1, and the internal temperatures of the second heat-retaining devices 2a and 2b were measured for 48 hours with medicines contained in each of the second heat-retaining devices 2a and 2b.
[0050] The second insulation device 2a aims to control the internal temperature in the refrigerated zone (2°C to 8°C), while the second insulation device 2b aims to control the internal temperature in the room temperature zone (15°C to 25°C).
[0051] Thermocouples were installed at a total of 27 locations in the accommodation section 21 of the second heat retaining devices 2a and 2b to measure the temperature inside the second heat retaining devices 2. The accommodation section 21 of the second heat retaining devices 2a and 2b used in the demonstration experiment had a substantially rectangular parallelepiped shape.
[0052] In the test results shown in FIG. 7, the room temperature zone (15°C to 25°C) corresponds to the second temperature range of the above-mentioned embodiment, and the refrigerated zone (2°C to 8°C) corresponds to the third temperature range of the above-mentioned embodiment.
[0053] As shown in the test results in Figure 7, when the internal temperature (outside temperature) of the first insulation device 1 was 20°C and 25°C, it was within the target range in both the refrigerated zone (2°C to 8°C) and the room temperature zone (15°C to 25°C).
[0054] In addition, when the outside air temperature (first temperature range) is 15°C, the temperature inside the second heat retaining device 2b is within the target range of the normal temperature zone (15°C to 25°C). Fitted within This is because the outside temperature was 15°C and the second heat retaining device 2b needed to heat the inside temperature instead of cooling it, which resulted in a lot of power consumption from the secondary battery, and the secondary battery ran out of power within 48 hours. Results It is possible.
[0055] Therefore, measurements were also taken only in the normal temperature zone (15°C to 25°C) when the outside air temperature was 17°C. In this case, the temperature inside the second heat retaining device 2b was within the target range in the normal temperature zone (15°C to 25°C).
[0056] As described above, from the results of the demonstration experiment shown in FIG. 7, it was found that the transportation method according to this embodiment can appropriately control the internal temperature in the second temperature range (15°C to 25°C) and the third temperature range (2°C to 8°C) when the first temperature range is 17°C to 25°C.
[0057] Although the embodiment of the present invention has been described above, the present invention is not limited to the above-described embodiment. Furthermore, the effects described in the present embodiment are merely a list of the most preferable effects resulting from the present invention, and the effects of the present invention are not limited to those described in the present embodiment. [Explanation of symbols]
[0058] 1. First Heating Device 2. Second Heat Retention Device 3. Land Transportation 4 Maritime Transportation
Claims
1. A method for transporting medicines using a first heat-retaining device that is driven by an external power source and that controls an internal temperature within a first temperature range, and a second heat-retaining device that is driven by a secondary battery and that controls an internal temperature within a second temperature range, comprising: The method includes a step of housing the second heat-keeping device in the first heat-keeping device, and transporting the first heat-keeping device in a state in which the medicine is housed in the second heat-keeping device; The first temperature range is set between a value higher than the lower limit of the second temperature range by a predetermined range and an upper limit of the second temperature range, and the predetermined range is 0°C to 2°C. How medicines are transported.
2. When a plurality of the second heat retaining devices are housed in the first heat retaining device, at least one of the second heat retaining devices is capable of managing an internal temperature within a third temperature range; The third temperature range is a temperature range lower than the second temperature range.
2. A method for delivering a pharmaceutical product according to claim 1.
Citation Information
Patent Citations
Control method of starting of on-vehicle cold roll box
JP1993001872A
refrigerator car
JP1993074985U
Thermally insulated transportation container and method of transportation under thermally insulated condition
JP2007064544A
Accommodation unit, temperature management system, and program
JP2017040466A
Transportation method
JP2019043651A
